Georgios Anagnostopoulos

Georgios Anagnostopoulos

Site Relationship and Excellence Partner, Global Site and Study Operations, Pfizer Global Product Development

George Anagnostopoulos graduated from the Medical School of the Aristotle University of Thessaloniki on 1992 and after the Medical Residency in Internal Medicine he practiced Medicine in the Hepatology Departments of 2 private clinics until 2009. From 1996 to 2009 he acted as Sub-Investigator in 17 Phase II-III clinical trials and in parallel was trainer of CRO and pharmaceutical company executives. From 2003 to 2005 was responsible for the medical oversight of serious adverse events of Phase II clinical study of Wyeth. From 2009 to 2016 he was responsible for the Medical Oversight of high-risk clinical trials of Pfizer in Hellas, Malta and Cyprus. From 2016 to 2019 he was responsible for the operational supervision of clinical trials in Hellas and medical oversight of Pfizer clinical trials conducted in Hellas and Western Europe. Since 2019, he is responsible for the supervision of excellence and operational execution of Pfizer interventional clinical trials in Hellas.

Speaker Details